Market Overview:
The global itraconazole market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of fungal infections, increasing demand for generic drugs and growing awareness about fungal infections. Based on type, the global itraconazole market is segmented into capsule, cream, tablet and injection. Capsule held the largest share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its ease of use and high efficacy against various types of fungi. Tablet held second largest share in 2017 owing to its low cost as compared to other formulations available in the market.
Product Definition:
Itraconazole is a medication used to treat fungal infections. It may be used to treat fungal infections of the skin, nails, mouth, throat, lungs, and urinary tract. It is also used to prevent or treat fungus infections in people with HIV/AIDS.
Capsule:
Capsule is a small container that holds the medicine and it's used to administer the drug. It can be oral or transdermal depending on the type of medication. The capsule is made up of gelatin, which is an animal by-product, and therefore people who are allergic to animals should not take capsules. The size of capsule depends upon two factors: Type of Medicine (solid or liquid) and Dose (Sedentary or Active).
Cream:
Cream is a topical medication used for the treatment of dermatological conditions such as psoriasis, eczema and acne. It contains an active ingredient called itraconazole nitrate which helps in reducing skin cell growth and relieves itching. It also has anti-inflammatory properties that reduce redness & swelling caused by rashes. Creams are available in different forms such as gels, creams, lotions & ointments among others.
Application Insights:
The global itraconazole market by application is categorized into hospital, pharmacy, and clinics. The hospitals segment dominated the overall industry in terms of revenue in 2017. This is due to factors such as high product demand for fungal infections caused by Itraconazole & Terconazole derivatives such as athlete's foot, jock itch and yeast infection. In addition, increasing awareness about these antifungal agents among healthcare professionals also contributes to the segment growth.
Pharmacies are expected to be the fastest-growing segment over the forecast period owing to factors such as growing product demand for treating various skin conditions including eczema and psoriasis that often occur during winters along with other chronic diseases like diabetes that require longterm medication management.
Regional Analysis:
North America dominated the global itraconazole market in 2017. The presence of a large number of manufacturers coupled with high R&D investment by companies is expected to drive the regional market over the forecast period. Furthermore, increasing cases of fungal infections are anticipated to fuel product demand in North America. For instance, according to data published by CDC, in 2016 approximately 6 million people were diagnosed with invasive fungal diseases like aspergillosis and Candida infection which resulted into deaths approximately 33% higher than 2015.
Asia Pacific is expected to be one of the fastest growing regions due its rapidly expanding medical sector coupled with rising disposable income and awareness about healthcare facilities among patients especially rural population living far away from urban centers thus resulting into increased incidence rate for mushroom-related disorders such as dermatophytosis andCandidiasis (thrush).
Growth Factors:
- Increasing incidence of fungal infections: The increasing incidence of fungal infections is one of the key growth drivers for the Itraconazole market. Fungal infections are caused by a group of microorganisms, which include yeasts, molds, and dermatophytes. These microorganisms can cause serious health problems in humans and animals. According to the Centers for Disease Control and Prevention (CDC), around 6 million people in the U.S are affected by fungal infection every year, out of which 3 million cases are diagnosed as serious enough to require hospitalization. This growing prevalence of fungal infections is expected to drive demand for Itraconazole products in the coming years.
- Rising awareness about antifungal therapies: The rising awareness about antifungal therapies is another major factor that is expected to boost demand for Itraconazole products in the coming years. People are becoming increasingly aware about the dangers posed by various types of fungi and their potential impact on human health, which has led to an increase in demand for effective antifungal therapies such as Itraconazole products .
Scope Of The Report
Report Attributes
Report Details
Report Title
Itraconazole Market Research Report
By Type
Capsule, Cream, Tablet, Injection
By Application
Hospital, Pharmacy, Clinics
By Companies
Smilax Laboratories, Ultratech Pharmaceuticals, Nifty Labs, Janssen Pharmaceutica, Mylan, Medisys Biotech, Chengdu Beite Pharmaceutical, Tianjin Lisheng Pharmaceutical, Le Pu Pharmaceutical, Chongqing Hua Bangshengkai Pharmacy, Sichuan Renan Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Itraconazole Market Report Segments:
The global Itraconazole market is segmented on the basis of:
Types
Capsule, Cream, Tablet, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smilax Laboratories
- Ultratech Pharmaceuticals
- Nifty Labs
- Janssen Pharmaceutica
- Mylan
- Medisys Biotech
- Chengdu Beite Pharmaceutical
- Tianjin Lisheng Pharmaceutical
- Le Pu Pharmaceutical
- Chongqing Hua Bangshengkai Pharmacy
- Sichuan Renan Pharmaceutical
Highlights of The Itraconazole Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsule
- Cream
- Tablet
- Injection
- By Application:
- Hospital
- Pharmacy
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Itraconazole Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Itraconazole is a medication used to treat fungal infections. It works by stopping the growth of the fungus.
Some of the key players operating in the itraconazole market are Smilax Laboratories, Ultratech Pharmaceuticals, Nifty Labs, Janssen Pharmaceutica, Mylan, Medisys Biotech, Chengdu Beite Pharmaceutical, Tianjin Lisheng Pharmaceutical, Le Pu Pharmaceutical, Chongqing Hua Bangshengkai Pharmacy, Sichuan Renan Pharmaceutical.
The itraconazole market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Itraconazole Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Itraconazole Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Itraconazole Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Itraconazole Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Itraconazole Market Size & Forecast, 2018-2028
4.5.1 Itraconazole Market Size and Y-o-Y Growth
4.5.2 Itraconazole Market Absolute $ Opportunity
Chapter 5 Global Itraconazole Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Itraconazole Market Size Forecast by Type
5.2.1 Capsule
5.2.2 Cream
5.2.3 Tablet
5.2.4 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Itraconazole Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Itraconazole Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Itraconazole Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Itraconazole Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Itraconazole Analysis and Forecast
9.1 Introduction
9.2 North America Itraconazole Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Itraconazole Market Size Forecast by Type
9.6.1 Capsule
9.6.2 Cream
9.6.3 Tablet
9.6.4 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Itraconazole Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.10.3 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Itraconazole Analysis and Forecast
10.1 Introduction
10.2 Europe Itraconazole Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Itraconazole Market Size Forecast by Type
10.6.1 Capsule
10.6.2 Cream
10.6.3 Tablet
10.6.4 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Itraconazole Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.10.3 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Itraconazole Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Itraconazole Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Itraconazole Market Size Forecast by Type
11.6.1 Capsule
11.6.2 Cream
11.6.3 Tablet
11.6.4 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Itraconazole Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.10.3 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Itraconazole Analysis and Forecast
12.1 Introduction
12.2 Latin America Itraconazole Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Itraconazole Market Size Forecast by Type
12.6.1 Capsule
12.6.2 Cream
12.6.3 Tablet
12.6.4 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Itraconazole Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.10.3 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Itraconazole Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Itraconazole Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Itraconazole Market Size Forecast by Type
13.6.1 Capsule
13.6.2 Cream
13.6.3 Tablet
13.6.4 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Itraconazole Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.10.3 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Itraconazole Market: Competitive Dashboard
14.2 Global Itraconazole Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Smilax Laboratories
14.3.2 Ultratech Pharmaceuticals
14.3.3 Nifty Labs
14.3.4 Janssen Pharmaceutica
14.3.5 Mylan
14.3.6 Medisys Biotech
14.3.7 Chengdu Beite Pharmaceutical
14.3.8 Tianjin Lisheng Pharmaceutical
14.3.9 Le Pu Pharmaceutical
14.3.10 Chongqing Hua Bangshengkai Pharmacy
14.3.11 Sichuan Renan Pharmaceutical
